Stockscreener 앱 받기
3.945
1.81%
0.075
전일 마감가:
$3.87
열려 있는:
$3.91
하루 거래량:
529.69K
Relative Volume:
0.59
시가총액:
$224.61M
수익:
-
순이익/손실:
$-82.44M
주가수익비율:
-2.0984
EPS:
-1.88
순현금흐름:
$-66.75M
1주 성능:
-0.25%
1개월 성능:
+1.29%
6개월 성능:
+121.35%
1년 성능:
+36.33%
1일 변동 폭
$3.76
$3.97
1주일 범위
$3.71
$4.08
52주 변동 폭
$1.195
$4.45
Black Diamond Therapeutics Inc Stock (BDTX) Company Profile
명칭
Black Diamond Therapeutics Inc
전화
617-417-5868
주소
ONE MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA
BDTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BDTX
Black Diamond Therapeutics Inc
|
3.945 | 220.34M | 0 | -82.44M | -66.75M | -1.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.23 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
641.92 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.67 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
825.18 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.14 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Black Diamond Therapeutics Inc Stock (BDTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-16 | 재개 | Stifel | Buy |
| 2025-09-04 | 개시 | Guggenheim | Buy |
| 2025-07-01 | 재개 | Raymond James | Outperform |
| 2024-07-31 | 개시 | Raymond James | Outperform |
| 2023-07-14 | 개시 | Piper Sandler | Overweight |
| 2023-06-30 | 업그레이드 | Stifel | Hold → Buy |
| 2023-06-28 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-06-27 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2022-03-29 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2022-03-22 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2021-09-30 | 개시 | Stifel | Hold |
| 2021-01-07 | 개시 | Wedbush | Outperform |
| 2020-11-24 | 개시 | Berenberg | Buy |
| 2020-05-04 | 개시 | H.C. Wainwright | Buy |
| 2020-02-24 | 개시 | Canaccord Genuity | Buy |
| 2020-02-24 | 개시 | Cowen | Outperform |
| 2020-02-24 | 개시 | JP Morgan | Overweight |
| 2020-02-24 | 개시 | Jefferies | Buy |
모두보기
Black Diamond Therapeutics Inc 주식(BDTX)의 최신 뉴스
Volume spikes in Black Diamond Therapeutics Inc. stock – what they mean2025 AllTime Highs & Daily Profit Focused Screening - newser.com
Can Black Diamond Therapeutics Inc. stock hit record highs againLayoff News & Daily Volume Surge Trade Alerts - newser.com
Tools to assess Black Diamond Therapeutics Inc.’s risk profileRate Hike & Low Drawdown Investment Strategies - newser.com
Is Black Diamond Therapeutics Inc. trending in predictive chart modelsJuly 2025 PostEarnings & Daily Price Action Insights - newser.com
Can Black Diamond Therapeutics Inc. stock resist market sell offsTrade Signal Summary & Daily Technical Forecast Reports - newser.com
Can Black Diamond Therapeutics Inc. stock outperform in 2025 bull marketJuly 2025 Recap & High Accuracy Investment Entry Signals - newser.com
Real time scanner hits for Black Diamond Therapeutics Inc. explainedQuarterly Investment Review & Weekly Hot Stock Watchlists - newser.com
How geopolitical tensions affect Black Diamond Therapeutics Inc. stockMarket Weekly Review & Fast Entry High Yield Stock Tips - newser.com
Is Black Diamond Therapeutics Inc. building a consolidation baseWeekly Trade Review & Weekly Watchlist for Hot Stocks - newser.com
Should You Buy, Hold, or Sell BDTX Stock Ahead of Q3 Earnings? - sharewise.com
Volatility clustering patterns for Black Diamond Therapeutics Inc.Quarterly Portfolio Report & Daily Volume Surge Signals - newser.com
Using fundamentals and technicals on Black Diamond Therapeutics Inc.Earnings Overview Summary & Free High Return Stock Watch Alerts - newser.com
Chart based exit strategy for Black Diamond Therapeutics Inc.2025 Historical Comparison & Smart Investment Allocation Tips - newser.com
What analysts say about Black Diamond Therapeutics Inc stockGrowth vs. Value Investing & Free Get High Impact Recommendations - earlytimes.in
Black Diamond Therapeutics (BDTX) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Published on: 2025-10-27 19:48:31 - newser.com
Published on: 2025-10-26 22:14:09 - newser.com
Black Diamond Therapeutics Inc (BDTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.26%
0.17%
자본화:
|
볼륨(24시간):